| Single-cell virus sequencing of influenza infections that trigger innate immunity AB Russell, E Elshina, JR Kowalsky, AJW Te Velthuis, JD Bloom Journal of virology 93 (14), 10.1128/jvi. 00500-19, 2019 | 106 | 2019 |
| Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target E Yángüez, A Hunziker, MP Dobay, S Yildiz, S Schading, E Elshina, ... Nature communications 9 (1), 3679, 2018 | 53 | 2018 |
| The influenza virus RNA polymerase as an innate immune agonist and antagonist E Elshina, AJW Te Velthuis Cellular and Molecular Life Sciences 78 (23), 7237-7256, 2021 | 13 | 2021 |
| Transient RNA structures cause aberrant influenza virus replication and innate immune activation H French, E Pitré, MS Oade, E Elshina, K Bisht, A King, DLV Bauer, ... Science Advances 8 (36), eabp8655, 2022 | 11 | 2022 |
| Inhibition of antigen-specific and nonspecific stimulation of bovine T and B cells by lymphostatin from attaching and effacing Escherichia coli RL Cassady-Cain, EA Blackburn, CR Bell, E Elshina, JC Hope, ... Infection and immunity 85 (2), 10.1128/iai. 00845-16, 2017 | 9 | 2017 |
| Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease E Elshina, ER Allen, A Flaxman, PM van Diemen, A Milicic, CS Rollier, ... Vaccine 37 (3), 502-509, 2019 | 3 | 2019 |
| Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination A Flaxman, Y Yamaguchi, PM van Diemen, C Rollier, E Allen, E Elshina, ... Vaccine 37 (3), 494-501, 2019 | 1 | 2019 |
| Cas13-based amplification-free quantification of aberrant RNAs during influenza virus infection CH Lamb, EM Pitré, E Elshina, CV Rigby, K Bisht, H Jalal, C Myhrvold, ... bioRxiv, 2023 | | 2023 |
| Investigating the mechanisms behind the immunostimulatory activity of influenza A virus RNA polymerase mutations E Elshina | | 2023 |
